# Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences

**Authors:** Gabriella Schiera, Giulia Macajone, Sara Volpes, Laura Greco, Carlo Maria Di Liegro, Graziella Serio, Fabio Caradonna, Flores Naselli

PMC · DOI: 10.3390/cells15040366 · Cells · 2026-02-18

## TL;DR

This paper reviews how poor maternal nutrition during pregnancy can lead to long-term health issues in offspring, including obesity, metabolic disorders, and cognitive problems.

## Contribution

The paper highlights the role of maternal overnutrition and gestational diabetes in fetal programming and discusses epigenetic and metabolic mechanisms.

## Key findings

- Maternal overnutrition alters fetal metabolic pathways and increases susceptibility to metabolic syndrome.
- Maternal obesity is linked to cognitive dysfunction and elevated cancer-related mortality in offspring.
- Epigenetic changes from maternal overnutrition may be transgenerational, and paternal obesity also affects fetal programming.

## Abstract

Maternal nutrition during pregnancy critically influences fetal programming, shaping the offspring’s lifelong health and disease susceptibility. Both undernutrition and overnutrition affect fetal metabolism, predisposing offspring to obesity and cardiometabolic disorders in adulthood. This review examines current evidence on how maternal nutrition, particularly overnutrition and its complications, such as gestational diabetes mellitus (GDM) and obesity, affects offspring health. It also explores the biochemical and epigenetic mechanisms underlying aberrant fetal programming induced by an unfavorable intrauterine environment. Excess nutrient exposure in utero alters fetal metabolic pathways by modifying the expression of key metabolic genes and nutrient sensors, increasing susceptibility to metabolic syndrome later in life. Maternal obesity has additionally been linked to cognitive dysfunction, immune alterations, and elevated cancer-related mortality in the offspring. GDM exposure disrupts fetal hypothalamic development, impairing appetite regulation. Emerging evidence suggests that epigenetic changes induced by maternal overnutrition may be transmitted across generations and that paternal obesity may also contribute to fetal metabolic programming. Although lifestyle interventions during pregnancy have been tested, they show limited long-term benefits, whereas pre-pregnancy BMI remains the strongest predictor of offspring obesity, emphasizing the critical role of preconception care and the prevention of overweight in women of reproductive age.

## Linked entities

- **Diseases:** gestational diabetes mellitus (MONDO:0005406), obesity (MONDO:0011122), metabolic syndrome (MONDO:0000816), cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, SLC5A5 (solute carrier family 5 member 5) [NCBI Gene 6528] {aka NIS, TDH1}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, TFR2 (transferrin receptor 2) [NCBI Gene 7036] {aka HFE3, TFRC2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, VTRNA2-1 (vault RNA 2-1) [NCBI Gene 100126299] {aka CBL-3, CBL3, MIR886, MIRN886, VTRNA2, hsa-mir-886}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, TCF7L2 (transcription factor 7 like 2) [NCBI Gene 6934] {aka TCF-4, TCF4}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, TSHR (thyroid stimulating hormone receptor) [NCBI Gene 7253] {aka CHNG1, LGR3, hTSHR-I}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, MTNR1B (melatonin receptor 1B) [NCBI Gene 4544] {aka FGQTL2, MEL-1B-R, MT2}, SHBG (sex hormone binding globulin) [NCBI Gene 6462] {aka ABP, SBP, TEBG}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 6515] {aka GLUT3}, RBP4 (retinol binding protein 4) [NCBI Gene 5950] {aka MCOPCB10, RDCCAS}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}, RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, CSH2 (chorionic somatomammotropin hormone 2) [NCBI Gene 1443] {aka CS-2, CSB, GHB1, PL, hCS-B}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, Pomc (pro-opiomelanocortin-alpha) [NCBI Gene 18976] {aka ACTH, BE, Beta-LPH, Clip, Gamma-LPH, Npp}, MC4R (melanocortin 4 receptor) [NCBI Gene 4160] {aka BMIQ20}
- **Diseases:** coronary heart disease (MESH:D003327), growth delay (MESH:D006130), mitochondrial damage (MESH:D028361), congenital malformations (OMIM:163000), dyslipidemia (MESH:D050171), night blindness (MESH:D009755), ASD (MESH:D000067877), Hyperglycemia (MESH:D006943), cardiometabolic complications (MESH:D024821), IUGR (MESH:D005317), spastic diplegia (MESH:D002547), platelet aggregation (MESH:D001791), congenital anomalies (MESH:D000013), iron overload (MESH:D019190), inflammation (MESH:D007249), respiratory infections (MESH:D012141), injury to (MESH:D014947), disease (MESH:D004194), impaired glucose metabolism (MESH:D044882), Maternal Overnutrition (MESH:D044343), preeclampsia (MESH:D011225), cancer (MESH:D009369), thyroid hypofunction (MESH:D000309), macrosomia (MESH:D005320), endothelial dysfunction (MESH:D014652), Diabetes (MESH:D003920), NAFLD (MESH:D065626), xerophthalmia (MESH:D014985), impairment in mental function (MESH:D001523), strabismus (MESH:D013285), vitamin D (MESH:D014808), Fetal deformities (MESH:D005315), stroke (MESH:D020521), overweight (MESH:D050177), learning and memory deficits (MESH:D007859), neurobehavioral disorders (MESH:D019954), deficiency of vitamin B12 (MESH:D014806), Obesity (MESH:D009765), Folic acid deficiency (MESH:D005494), GDM (MESH:D016640), structural defects (MESH:D020914), autoimmune diseases (MESH:D001327), weight gain (MESH:D015430), mood disorder (MESH:D019964), language disorders (MESH:D007806), hepatic steatosis (MESH:D005234), Iron deficiency (MESH:D000090463), blindness (MESH:D001766), iron deficiency anemia (MESH:D018798), pulmonary embolism (MESH:D011655), NTD (MESH:D009436), thyroid alterations (MESH:D013966), sensorineural deafness (MESH:D006319), metabolic disease (MESH:D008659), emotional dysregulation (MESH:D021081), placental ischemia (MESH:D007511), atherogenic (MESH:D050197), pregnancy complication (MESH:D011248), folate deficiency (MESH:C562799), hyperinsulinemia (MESH:D006946)
- **Chemicals:** oxygen (MESH:D010100), zinc (MESH:D015032), phosphate (MESH:D010710), sugar (MESH:D000073893), Vitamin D (MESH:D014807), fat (MESH:D005223), methionine (MESH:D008715), thymine (MESH:D013941), triglyceride (MESH:D014280), cortisol (MESH:D006854), uracil (MESH:D014498), STZ (MESH:D013311), Vitamin A (MESH:D014801), AdoMet (MESH:D012436), Iron (MESH:D007501), FFAs (MESH:D005230), phospholipids (MESH:D010743), Blood glucose (MESH:D001786), cholesterol (MESH:D002784), C-peptide (MESH:D002096), conjugated linoleic acid (MESH:D044243), vitamin C (MESH:D001205), progesterone (MESH:D011374), GABA (MESH:D005680), BCAA (MESH:D000597), norepinephrine (MESH:D009638), 25-hydroxyvitamin D (MESH:C104450), retinoic acid (MESH:D014212), D (MESH:D003903), ferric (-), FAs (MESH:D005227), selenium (MESH:D012643), homocysteine (MESH:D006710), amino acid (MESH:D000596), Iodine (MESH:D007455), vitamin B12 (MESH:D014805), lipid (MESH:D008055), 13-cis-retinoic acid (MESH:D015474), steroid hormones (MESH:D013256), Folate (MESH:D005492), heavy metals (MESH:D019216), calcium (MESH:D002118), serotonin (MESH:D012701), glucose (MESH:D005947), dopamine (MESH:D004298)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** C > D

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939028/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939028/full.md

## References

186 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939028/full.md

---
Source: https://tomesphere.com/paper/PMC12939028